rotate-mobile
Lunedì, 4 Luglio 2022
Salute

Strekin AG Announces Completion of Patient Recruitment in the RESTORE Phase 3 Clinical Study of STR001



In Evidenza

Potrebbe interessarti

Strekin AG Announces Completion of Patient Recruitment in the RESTORE Phase 3 Clinical Study of STR001

Today è in caricamento